Rash as a Surrogate Marker for Efficacy of Epidermal Growth Factor Receptor Inhibitors in Lung Cancer-Reference-Cited by-同舟云学术

Rash as a Surrogate Marker for Efficacy of Epidermal Growth Factor Receptor Inhibitors in Lung Cancer

Published:2006-12 Issue: Volume:8 Page:S7-S14
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Perez-Soler Roman

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference57 articles.

1. Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype;Fontanini;Eur J Cancer,1995

2. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung;Rusch;Cancer Res,1993

3. Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression;Ohsaki;Oncol Rep,2000

4. Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer;Selvaggi;Ann Oncol,2004

5. The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival;Veale;Br J Cancer,1993

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highly variable timing renders immunotherapy efficacy and toxicity impractical biomarkers of one another in clinical practice;Frontiers in Immunology;2024-04-16

2. Cutaneous toxicities of mitogen-activated protein kinase inhibitors in children and young adults with neurofibromatosis-1;Journal of Neuro-Oncology;2024-03-05

3. Dermatologic toxicities in epidermal growth factor receptor: a comprehensive pharmacovigilance study from 2013 to 2023;Frontiers in Medicine;2024-01-24

5. Recent advances in non-small cell lung cancer targeted therapy; an update review;Cancer Cell International;2023-08-11